October 2021 – Page 2 – Policy & Medicine

Illinois Health Care Professionals Must Learn About Alzheimer’s

FDA Issues Draft Guidance on RWD Sourced from EHRs and Medical Claims Data

FDA REMS Pain Management and Opioid Therapy: Persistent Knowledge Gaps Among Primary Care Providers Rockpointe Program Shows Need for More Healthcare Provider Education

Oregon Publishes Proposed Rules on Pharmaceutical Representative Licensure & Disclosure

FDA Requests Input on How to Handle Post-Approval Regulation of PANDAs

CMS Issues IPPS Final Rule for FY 2022

California Law Makes Changes to CME

Biopharmaceutical Companies Send Open Letter to Congress

Three Generic Pharmaceutical Manufacturers Agree to $447 Million Settlement for False Claims Act Violations

CME Coalition Endorses Several Bills in Congress Supporting CME